A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Andrew Mastro, PA-C
Virtual (Zoom)
This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Kathryn Sowerwine, MD
Virtual (Zoom)
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Raj Chovatiya, MD
Virtual (Zoom)
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years of age.
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Justin Greiwe, MD
Virtual (Zoom)
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
Clinical Case Discussion: An Adult Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
by Andrew Baker, PA-C
Virtual (Zoom)
Join us for a program discussing a real-world case of an adult patient with moderate-to-severe atopic dermatitis (AD) and a treatment option that may help appropriate patients with Type 2 inflammation.
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Justin Love, PA-C
Virtual (Zoom)
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Gina Mangin, PA-C
Virtual (Zoom)
This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. Register
Exploring the Pathophysiology of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Cynthia Trickett, PA-C
Virtual (Zoom)
Learn more about the evolving understanding of the pathophysiology of chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate CSU patients 12+ years of age.
DUPIXENT@ (dupilumab) Pediatric Caregiver Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Lisa Swanson, MD
Virtual (Zoom)
Join us for a virtual discussion with an expert speaker and a caregiver of a pediatric patient with atopic dermatitis (AD) to learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
by Ty Hanson, DO
Virtual (Zoom)
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation